Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2017-2028
2.1.2 Global Influenza Vaccine Sales 2017-2028
2.2 Influenza Vaccine Market Size by Region: 2022 Versus 2028
2.3 Influenza Vaccine Sales by Region (2017-2028)
2.3.1 Global Influenza Vaccine Sales by Region: 2017-2022
2.3.2 Global Influenza Vaccine Sales Forecast by Region (2023-2028)
2.3.3 Global Influenza Vaccine Sales Market Share by Region (2017-2028)
2.4 Influenza Vaccine Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Influenza Vaccine Revenue by Region: 2017-2022
2.4.2 Global Influenza Vaccine Revenue Forecast by Region (2023-2028)
2.4.3 Global Influenza Vaccine Revenue Market Share by Region (2017-2028)
3 Global Influenza Vaccine by Manufacturers
3.1 Global Top Influenza Vaccine Manufacturers by Sales
3.1.1 Global Influenza Vaccine Sales by Manufacturer (2017-2022)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Influenza Vaccine Revenue by Manufacturer (2017-2022)
3.2.2 Global Influenza Vaccine Revenue Share by Manufacturer (2017-2022)
3.3 Global Influenza Vaccine Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Influenza Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Influenza Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Sanofi
4.1.1 Sanofi Corporation Information
4.1.2 Sanofi Description, Business Overview
4.1.3 Sanofi Influenza Vaccine Products Offered
4.1.4 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Sanofi Influenza Vaccine Sales by Product in 2021
4.1.6 Sanofi Influenza Vaccine Sales by Application in 2021
4.1.7 Sanofi Influenza Vaccine Sales by Geographic Area in 2021
4.1.8 Sanofi Recent Developments
4.2 CSL
4.2.1 CSL Corporation Information
4.2.2 CSL Description, Business Overview
4.2.3 CSL Influenza Vaccine Products Offered
4.2.4 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.2.5 CSL Influenza Vaccine Sales by Product in 2021
4.2.6 CSL Influenza Vaccine Sales by Application in 2021
4.2.7 CSL Influenza Vaccine Sales by Geographic Area in 2021
4.2.8 CSL Recent Developments
4.3 GSK
4.3.1 GSK Corporation Information
4.3.2 GSK Description, Business Overview
4.3.3 GSK Influenza Vaccine Products Offered
4.3.4 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.3.5 GSK Influenza Vaccine Sales by Product in 2021
4.3.6 GSK Influenza Vaccine Sales by Application in 2021
4.3.7 GSK Influenza Vaccine Sales by Geographic Area in 2021
4.3.8 GSK Recent Developments
4.4 Viatris
4.4.1 Viatris Corporation Information
4.4.2 Viatris Description, Business Overview
4.4.3 Viatris Influenza Vaccine Products Offered
4.4.4 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Viatris Influenza Vaccine Sales by Product in 2021
4.4.6 Viatris Influenza Vaccine Sales by Application in 2021
4.4.7 Viatris Influenza Vaccine Sales by Geographic Area in 2021
4.4.8 Viatris Recent Developments
4.5 AstraZeneca
4.5.1 AstraZeneca Corporation Information
4.5.2 AstraZeneca Description, Business Overview
4.5.3 AstraZeneca Influenza Vaccine Products Offered
4.5.4 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.5.5 AstraZeneca Influenza Vaccine Sales by Product in 2021
4.5.6 AstraZeneca Influenza Vaccine Sales by Application in 2021
4.5.7 AstraZeneca Influenza Vaccine Sales by Geographic Area in 2021
4.5.8 AstraZeneca Recent Developments
4.6 Hualan Bio
4.6.1 Hualan Bio Corporation Information
4.6.2 Hualan Bio Description, Business Overview
4.6.3 Hualan Bio Influenza Vaccine Products Offered
4.6.4 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Hualan Bio Influenza Vaccine Sales by Product in 2021
4.6.6 Hualan Bio Influenza Vaccine Sales by Application in 2021
4.6.7 Hualan Bio Influenza Vaccine Sales by Geographic Area in 2021
4.6.8 Hualan Bio Recent Development
4.7 Changchun Institute of Biological
4.7.1 Changchun Institute of Biological Corporation Information
4.7.2 Changchun Institute of Biological Description, Business Overview
4.7.3 Changchun Institute of Biological Influenza Vaccine Products Offered
4.7.4 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Changchun Institute of Biological Influenza Vaccine Sales by Product in 2021
4.7.6 Changchun Institute of Biological Influenza Vaccine Sales by Application in 2021
4.7.7 Changchun Institute of Biological Influenza Vaccine Sales by Geographic Area in 2021
4.7.8 Changchun Institute of Biological Recent Development
4.8 Sinovac
4.8.1 Sinovac Corporation Information
4.8.2 Sinovac Description, Business Overview
4.8.3 Sinovac Influenza Vaccine Products Offered
4.8.4 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Sinovac Influenza Vaccine Sales by Product in 2021
4.8.6 Sinovac Influenza Vaccine Sales by Application in 2021
4.8.7 Sinovac Influenza Vaccine Sales by Geographic Area in 2021
4.8.8 Sinovac Recent Development
4.9 BCHT
4.9.1 BCHT Corporation Information
4.9.2 BCHT Description, Business Overview
4.9.3 BCHT Influenza Vaccine Products Offered
4.9.4 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.9.5 BCHT Influenza Vaccine Sales by Product in 2021
4.9.6 BCHT Influenza Vaccine Sales by Application in 2021
4.9.7 BCHT Influenza Vaccine Sales by Geographic Area in 2021
4.9.8 BCHT Recent Development
4.10 Jiangsu GDK
4.10.1 Jiangsu GDK Corporation Information
4.10.2 Jiangsu GDK Description, Business Overview
4.10.3 Jiangsu GDK Influenza Vaccine Products Offered
4.10.4 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Jiangsu GDK Influenza Vaccine Sales by Product in 2021
4.10.6 Jiangsu GDK Influenza Vaccine Sales by Application in 2021
4.10.7 Jiangsu GDK Influenza Vaccine Sales by Geographic Area in 2021
4.10.8 Jiangsu GDK Recent Development
4.11 KM Biologics
4.11.1 KM Biologics Corporation Information
4.11.2 KM Biologics Description, Business Overview
4.11.3 KM Biologics Influenza Vaccine Products Offered
4.11.4 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.11.5 KM Biologics Influenza Vaccine Sales by Product in 2021
4.11.6 KM Biologics Influenza Vaccine Sales by Application in 2021
4.11.7 KM Biologics Influenza Vaccine Sales by Geographic Area in 2021
4.11.8 KM Biologics Recent Development
5 Breakdown Data by Type
5.1 Global Influenza Vaccine Sales by Type (2017-2028)
5.1.1 Global Influenza Vaccine Sales by Type (2017-2022)
5.1.2 Global Influenza Vaccine Sales Forecast by Type (2023-2028)
5.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Influenza Vaccine Revenue Forecast by Type (2017-2028)
5.2.1 Global Influenza Vaccine Revenue by Type (2017-2022)
5.2.2 Global Influenza Vaccine Revenue Forecast by Type (2023-2028)
5.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
5.3 Influenza Vaccine Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Influenza Vaccine Sales by Application (2017-2028)
6.1.1 Global Influenza Vaccine Sales by Application (2017-2022)
6.1.2 Global Influenza Vaccine Sales Forecast by Application (2023-2028)
6.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Influenza Vaccine Revenue Forecast by Application (2017-2028)
6.2.1 Global Influenza Vaccine Revenue by Application (2017-2022)
6.2.2 Global Influenza Vaccine Revenue Forecast by Application (2023-2028)
6.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
6.3 Influenza Vaccine Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Influenza Vaccine Market Size YoY Growth 2017-2028
7.2 North America Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Influenza Vaccine Sales by Country (2017-2028)
7.2.2 North America Influenza Vaccine Revenue by Country (2017-2028)
7.3 North America Influenza Vaccine Sales by Type
7.4 North America Influenza Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Influenza Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Influenza Vaccine Sales by Region (2017-2028)
8.2.2 Asia-Pacific Influenza Vaccine Revenue by Region (2017-2028)
8.3 Asia-Pacific Influenza Vaccine Sales by Type
8.4 Asia-Pacific Influenza Vaccine Sales by Application
9 Europe
9.1 Europe Influenza Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Influenza Vaccine Market Facts & Figures by Country
9.2.1 Europe Influenza Vaccine Sales by Country (2017-2028)
9.2.2 Europe Influenza Vaccine Revenue by Country (2017-2028)
9.3 Europe Influenza Vaccine Sales by Type
9.4 Europe Influenza Vaccine Sales by Application
10 Latin America
10.1 Latin America Influenza Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccine Sales by Country (2017-2028)
10.2.2 Latin America Influenza Vaccine Revenue by Country (2017-2028)
10.3 Latin America Influenza Vaccine Sales by Type
10.4 Latin America Influenza Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028)
11.2.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028)
11.3 Middle East and Africa Influenza Vaccine Sales by Type
11.4 Middle East and Africa Influenza Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Influenza Vaccine Supply Chain Analysis
12.2 Influenza Vaccine Key Raw Materials and Upstream Suppliers
12.3 Influenza Vaccine Clients Analysis
12.4 Influenza Vaccine Sales Channel and Sales Model Analysis
12.4.1 Influenza Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Influenza Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Influenza Vaccine Distributors
13 Market Dynamics
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Influenza Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
Table 7. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 8. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Influenza Vaccine Sales by Manufacturer (2017-2022) & (M Doses)
Table 11. Global Influenza Vaccine Sales Share by Manufacturer (2017-2022)
Table 12. Influenza Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Influenza Vaccine Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Influenza Vaccine Price (2017-2022) & (USD/Doses)
Table 15. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2021)
Table 18. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Influenza Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Influenza Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Sanofi Corporation Information
Table 23. Sanofi Description and Business Overview
Table 24. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 25. Sanofi Influenza Vaccine Product
Table 26. Sanofi Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 27. Sanofi Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 28. Sanofi Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 29. Sanofi Recent Development
Table 30. CSL Corporation Information
Table 31. CSL Description and Business Overview
Table 32. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 33. CSL Influenza Vaccine Product
Table 34. CSL Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 35. CSL Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 36. CSL Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 37. CSL Recent Development
Table 38. GSK Corporation Information
Table 39. GSK Description and Business Overview
Table 40. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 41. GSK Influenza Vaccine Product
Table 42. GSK Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 43. GSK Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 44. GSK Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 45. GSK Recent Development
Table 46. Viatris Corporation Information
Table 47. Viatris Description and Business Overview
Table 48. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 49. Viatris Influenza Vaccine Product
Table 50. Viatris Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 51. Viatris Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 52. Viatris Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 53. Viatris Recent Development
Table 54. AstraZeneca Corporation Information
Table 55. AstraZeneca Description and Business Overview
Table 56. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 57. AstraZeneca Influenza Vaccine Product
Table 58. AstraZeneca Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 59. AstraZeneca Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 60. AstraZeneca Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 61. AstraZeneca Recent Development
Table 62. Hualan Bio Corporation Information
Table 63. Hualan Bio Description and Business Overview
Table 64. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 65. Hualan Bio Influenza Vaccine Product
Table 66. Hualan Bio Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 67. Hualan Bio Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 68. Hualan Bio Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 69. Changchun Institute of Biological Corporation Information
Table 70. Changchun Institute of Biological Description and Business Overview
Table 71. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 72. Changchun Institute of Biological Influenza Vaccine Product
Table 73. Changchun Institute of Biological Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 74. Changchun Institute of Biological Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 75. Changchun Institute of Biological Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 76. Sinovac Corporation Information
Table 77. Sinovac Description and Business Overview
Table 78. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 79. Sinovac Influenza Vaccine Product
Table 80. Sinovac Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 81. Sinovac Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 82. Sinovac Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 83. BCHT Corporation Information
Table 84. BCHT Description and Business Overview
Table 85. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 86. BCHT Influenza Vaccine Product
Table 87. BCHT Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 88. BCHT Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 89. BCHT Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 90. Jiangsu GDK Corporation Information
Table 91. Jiangsu GDK Description and Business Overview
Table 92. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 93. Jiangsu GDK Influenza Vaccine Product
Table 94. Jiangsu GDK Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 95. Jiangsu GDK Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 96. Jiangsu GDK Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 97. KM Biologics Corporation Information
Table 98. KM Biologics Description and Business Overview
Table 99. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 100. KM Biologics Influenza Vaccine Product
Table 101. KM Biologics Influenza Vaccine Sales Proportion of Influenza Vaccine by Product in 2021
Table 102. KM Biologics Influenza Vaccine Sales Proportion of Influenza Vaccine by Application in 2021
Table 103. KM Biologics Influenza Vaccine Sales Proportion of Influenza Vaccine by Geographic Area in 2021
Table 104. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 105. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 106. Global Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 107. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 108. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 109. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 110. Global Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 111. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 112. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 113. North America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
Table 114. North America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 115. North America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 116. North America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 117. North America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 118. Asia-Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
Table 119. Asia-Pacific Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
Table 120. Asia-Pacific Influenza Vaccine Revenue by Region (2017-2028) & (US$ Million)
Table 121. Asia-Pacific Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 122. Asia-Pacific Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 123. Asia-Pacific Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 124. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 125. Europe Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
Table 126. Europe Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 127. Europe Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 128. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 129. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 130. Latin America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 131. Latin America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
Table 132. Latin America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 133. Latin America Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 134. Latin America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 135. Latin America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 136. Middle East and Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 137. Middle East and Africa Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
Table 138. Middle East and Africa Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 139. Middle East and Africa Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 140. Middle East and Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 141. Middle East and Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
Table 142. Influenza Vaccine Key Raw Materials, Industry Status and Trend
Table 143. Influenza Vaccine Key Raw Materials and Upstream Suppliers
Table 144. Influenza Vaccine Clients Status and Trend
Table 145. Influenza Vaccine Typical Clients
Table 146. Influenza Vaccine Distributors
Table 147. Influenza Vaccine Market Trends
Table 148. Influenza Vaccine Market Drivers
Table 149. Influenza Vaccine Market Challenges
Table 150. Influenza Vaccine Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2021 & 2028
Figure 6. 6 Months to 3 Years Examples
Figure 7. > 3 Years Examples
Figure 8. Influenza Vaccine Report Years Considered
Figure 9. Global Influenza Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Influenza Vaccine Market Size 2017-2028 (US$ Million)
Figure 11. Global Influenza Vaccine Sales 2017-2028 (M Doses)
Figure 12. Global Influenza Vaccine Market Size Market Share by Region: 2022 Versus 2028
Figure 13. Global Influenza Vaccine Sales Market Share Forecast by Region (2017-2028)
Figure 14. Global Influenza Vaccine Revenue Market Share by Region (2017-2028)
Figure 15. Global Influenza Vaccine Sales Share by Manufacturer in 2021
Figure 16. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Influenza Vaccine Sales Market Share Forecast by Type (2017-2028)
Figure 18. Global Influenza Vaccine Revenue Market Share Forecast by Type (2017-2028)
Figure 19. Influenza Vaccine Average Selling Price (ASP) by Type (2017-2022) & (USD/Doses)
Figure 20. Global Influenza Vaccine Sales Market Share Forecast by Application (2017-2028)
Figure 21. Global Influenza Vaccine Revenue Market Share Forecast by Application (2017-2028)
Figure 22. Influenza Vaccine Average Selling Price (ASP) by Application (2017-2022) & (USD/Doses)
Figure 23. North America Influenza Vaccine Revenue 2017-2028 (US$ Million)
Figure 24. North America Influenza Vaccine Sales Market Share by Type (2017-2022)
Figure 25. North America Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 26. Asia-Pacific Influenza Vaccine Revenue 2017-2028 (US$ Million)
Figure 27. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2017-2028)
Figure 28. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Influenza Vaccine Sales Market Share by Type (2017-2022)
Figure 30. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 31. Europe Influenza Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Europe Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 33. Europe Influenza Vaccine Revenue Market Share by Country (2017-2028)
Figure 34. Europe Influenza Vaccine Sales Market Share by Type (2017-2022)
Figure 35. Europe Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 36. Latin America Influenza Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 37. Latin America Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 38. Latin America Influenza Vaccine Revenue Market Share by Country (2017-2022)
Figure 39. Latin America Influenza Vaccine Sales Market Share by Type (2017-2022)
Figure 40. Latin America Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 41. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
Figure 42. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2017-2028)
Figure 43. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2017-2022)
Figure 45. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 46. Influenza Vaccine Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Influenza Vaccine Raw Materials by Region in 2021
Figure 48. Influenza Vaccine Distribution Channels
Figure 49. Global Influenza Vaccine Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 50. Global Influenza Vaccine Percentage 2017-2028: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs